It's a bit of both ... some of it has been published and some is from experience. Most of mode (1) is documented in the original CTC documents (e.g. the HPN and Lancet articles by Steve Collins, Tanya Khara, Kate Sadler, and others; the CTC manual; &c.), in the documents arising from the CTC conferences which were published as ENN supplements and in a FNB supplement, and in the WHO/UNICEF/WFP joint statements on CMAM. The problems with using W/H are described briefly in some of the FNB articles and in a recent paper by Saul Guerrero and others: http://www.ncbi.nlm.nih.gov/pubmed/20002705 VALID International have been very active in CTC / CMAM programming (they also invented and finessed the model) and have a vast store of reports spanning over a decade which either address these issues directly or in passing. If you contact them they may be able to send you some reports and provide advice. The parts of mode (2) that are additional to mode (1) are less documented. I presented a paper at the Washington CTC / CMAM conference on MUAC response in CTC programs which should be available from the FANTA website. Some programs have adopted a MUAC-only strategy (contact VALID, SC-US, and WVI (I think) for details). FANTA-2 is funding a project to research MUAC discharge thresholds ... present knowledge suggests that 125 mm is safe but that a lower threshold (e.g. 120 mm without SFP or appropriate bridging program; 115 mm with SFP or appropriate bridging program). The main thrust for MUAC-only programming is MoH delivered CMAM which is usually devolved to the PHC level. Use of W/H is problematic here as height boards are not standard equipment, height is quite difficult to measure, and height measurements and W/H look-up / calculation are not covered in the IMCI syllabus. W/H is also not possible in CHW delivered CMAM programming as has recently been proved very effective (something like 96% recovery on 90% coverage) by by a joint research program by Tufts, SC-US, and the Government of Bangladesh. I hope this helps. |